Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

89Zr-AMG211 PET Imaging in Patients With Relapsed/Refractory Gastrointestinal Adenocarcinoma Before and During Treatment With AMG 211

NCT02760199 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT02760199
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02760199 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
89Zr-AMG211 PET Imaging in Patients With Relapsed/Refractory Gastrointestinal Adenocarcinoma Before and During Treatment With AMG 211
Lead sponsor
University Medical Center Groningen
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2016
Completion date
May 3, 2017
Enrollment
9 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced gastrointestinal cancer